RxforUSA

Product # : 1192774 Class : MCKSN Distributor : RELIANCE INC Category : Test Kits Availability : Stocked

$0.00

Product Notices : This product may be non-returnable and/or require additional restocking fee.

$797.89

- +

Add To Wishlist Add To Cart

Buy Now

Product No. #	1192774
Manufacturer #	256088
Brand	BD Veritor™ System
Manufacturer	BD
Country of Origin	China
Application	Respiratory Test Kit
For Use With	For use with the BD Veritor™ Plus Analyzer running Firmware version 5.50 or late
Number of Tests	30 Tests
Sample Type	Nasal Swab Sample
Shipping Width	8
Shipping Height	6
Shipping Depth	10
Dimension UOM	IC
Shipping Weight	1.6
Weight UOM	LB
For_Use_With	For use with the BD Veritor™ Plus Analyzer running Firmware version 5.50 or late
QTY_Per_Sell	1
Simply_Medical_Category	Test Kits
Reading_Type	Machine Read
Supply_Manager_Category	Test Kits
Supply_Manager_Hierarchy	Clinical Laboratory>Test Kits>Respiratory Test Kit
Legend_Code	Yes
Stock_Status	Stocked
Velocity	Fast Selling
GTIN	00382902560883
Country of Origin	China
Ready to Sell	Ready to sell

The BD Veritor System for Rapid Detection of SARS-CoV-2 and Flu A+B is intended for use in point of care settings by trained healthcare professionals or other users specifically instructed in the use of BD Veritor Systems and proper infection control procedures.
Time to result: 15 minutes, test device can be read at 15 minutes but no later than 20 minutes.
This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens.
BD Triplex assay requires Veritor™ System firmware version 5.5 or later; firmware version info is displayed on screen when turning on the analyzer or on the orange sticker if it is attached to the analyzer.
This test is authorized for use at the Point of Care (POC), i.e., in-patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests.